학술논문

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group.
Document Type
Article
Source
Innovations in Clinical Neuroscience; Jan-Mar2024, Vol. 21 Issue 1-3, p52-60, 9p
Subject
RARE diseases
CLINICAL trials
DRUG approval
STAKEHOLDER analysis
DRUG development
PATIENTS' attitudes
STANDARDS
Language
ISSN
21588333
Abstract
Copyright of Innovations in Clinical Neuroscience is the property of Matrix Medical Communications, LLC and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)